ClinicalTrials.Veeva

Menu

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Enrolling

Conditions

Facial Paralysis

Treatments

Procedure: Standard of Care surgery
Procedure: BES

Study type

Interventional

Funder types

Other

Identifiers

NCT06335719
IRB #22-926

Details and patient eligibility

About

A research study to find out if brief intraoperative electrical stimulation therapy improves nerve regeneration and smile outcomes following two-stage cross face nerve graft facial reanimation surgery.

Full description

Participants that choose to enroll in this study will be randomly assigned in a 2:1 ratio to a "treatment" or "control" group. In either group, patients will receive the same care as they normally would except for two minor differences. First, patients in both groups undergo nerve biopsies during surgery; these biopsies do not affect the length or outcome of surgery. Second, the treatment group will receive brief electrical stimulation therapy for approximately 10 minutes during the first stage cross-face nerve graft surgery.

The purpose of this study is to evaluate efficacy of an intraoperative dose of brief electrical stimulation (BES) to improve axonal regeneration across a cross-face nerve graft (CFNG) using nerve histology and to evaluate clinical outcomes of treatment and control groups using clinician graded, patient reported, and objective smile metric.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients 18-80 years-old with unilateral facial paralysis who are candidates for two- stage CFNG smile reanimation surgery (i.e. CFNG-driven free gracilis muscle transfer (FGMT) or dual innervation FGMT).
  2. Agree to participate in the study.

Exclusion criteria

  1. Bilateral facial paralysis
  2. Age less than 18 years-old or older than 80 years-old
  3. Comorbid medical condition preventing two-stage CFNG surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

Treatment Group
Experimental group
Description:
Treatment group undergoes nerve biopsies during surgery. In addition, patients in the treatment group receive brief electrical stimulation therapy for approximately 10 minutes during the first stage cross-face nerve graft surgery.
Treatment:
Procedure: BES
Control Group
Experimental group
Description:
Control group undergoes only nerve biopsies during surgery - no brief electrical stimulation.
Treatment:
Procedure: Standard of Care surgery

Trial contacts and locations

1

Loading...

Central trial contact

Hana Rosen, MD; John O'Neill, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems